SEC Form 4 · accession 0001209191-16-139490
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert B Bazemore
Officer — President & CEO · Director
Period of report
Aug 31, 2016
Accepted (ET)
Sep 1, 2016 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | Aug 31, 2016 | A | 1,362 | $6.2135 | A | 1,362 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Company's 2013 Employee Stock Purchase Plan in connection with the offering period ended August 31, 2016.